Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib

Theo D. Kim,Michaela Schwarz,Karl Anton Kreuzer,Jaspal Kaeda,Kamran Movassaghi,Peggy Grille,Peter T. Daniel,Bernd Dörken,Philipp le Coutre

Long-term follow-up of patients with Philadelphia chromosome-positive chronic myeloid leukemia after stem cell mobilization under imatinib

2011

Theo D. Kim
Michaela Schwarz
Karl Anton Kreuzer
Jaspal Kaeda
Kamran Movassaghi
Peggy Grille
Peter T. Daniel
Bernd Dörken
Philipp le Coutre

Based on the impressive results from the IRIS trial (International Randomized Interferon vs. STI-571), the tyrosine kinase inhibitor (TKI) imatinib mesylate (IM) has become the recommended first-li...

Keywords:

Oncology
Stem cell mobilization
Diabetes mellitus
Myeloid leukemia
Philadelphia Chromosome Positive
Imatinib
Immunology
Internal medicine
Medicine
long term follow up

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations